PRONIOSOMES: A SUPERIOR DRUG DELIVERY SYSTEM

Authors

  • D. Nagasamy Venkatesh Department of Pharmaceutics, JSS College of Pharmacy, (A Constituent College of JSS University, Mysore), Udhagamandalam – 643 001, Tamil Nadu, India
  • V. Swetha Priyanka Department of Pharmaceutics, JSS College of Pharmacy, (A Constituent College of JSS University, Mysore), Udhagamandalam – 643 001, Tamil Nadu, India
  • K. Tulasi Department of Pharmaceutics, JSS College of Pharmacy, (A Constituent College of JSS University, Mysore), Udhagamandalam – 643 001, Tamil Nadu, India
  • K. Kalyani Department of Pharmaceutics, JSS College of Pharmacy, (A Constituent College of JSS University, Mysore), Udhagamandalam – 643 001, Tamil Nadu, India
  • Sheik Abid Ali Department of Pharmaceutics, JSS College of Pharmacy, (A Constituent College of JSS University, Mysore), Udhagamandalam – 643 001, Tamil Nadu, India
  • Harikrishna Jilakara Department of Pharmaceutics, Jyothismathi College of Pharmacy, Thurkapally, Shamerpet, Rangareddy Dt. Hyderabad, Andhra Pradesh, India

Abstract

Proniosomes are solid colloidal particles which may be hydrated immediately before use to yield aqueous niosomes dispersions similar to those produced by more cumbersome conventional methods. The proniosomes minimize the problems associated with niosomes in terms of its physical stability such as aggregation, fusion and leaking. They also offer an additional convenience in transportation, distribution, storage, and dosing. The proniosomes derived niosomes are better than conventional niosomes in terms of their morphology, particle size, particle size distribution, and drug release. A slurry method was commonly used to produce proniosomes using maltodextrin as carrier. The time required to produce proniosomes by this simple method is independent of the ratio of surfactant solution to carrier material and appears to be a scalable process. The encapsulation efficiency of proniosomes is depends upon the amount of maltodextrin used in the process. The present review describes the method of preparation, characterization, applications of proniosomes as a potential drug delivery system.

Keywords:

Proniosomes, stability, drug release, permeability

DOI

https://doi.org/10.25004/IJPSDR.2014.060301

References

Almira I, Welesh AB, Rhodes DG. Maltodextrin based proniosomes. AAPS PharmSciTech. 2001; 3: Article 1.

Alsarra IA, Bosela AA, Ahmed SM, Maheous GM. Proniosomes as a drug carrier for transdermal delivery of ketoralac. Eur J Pharm Biopharm. 2005; 59:485-490.

Cevc G. Lipid vesicles and other colloids as drug carriers on the skin, Adv Drug Deliv Rev. 2006; 675-711.

Arunotharyanun P, Bernard MS, Craig DQH, Uchegbu TF, Florenace AT. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm. 2000; 201:7.

Gregoriadis G, Florence A, Harish M. Liposomes in drug delivery, Harwood academic publishers Langhorne PA, 1993, pp. 1085-1094.

Sudhamani T, Priyadarisini N. Proniosomes: A promising drug carriers. Int J Pharm Tech Res. 2010; 2: 1446-1454.

Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes non-ionic surfactant vesicles. J Pharm Pharmacol. 1985; 37: 863- 868.

Biju SS, Talegaonkar S, Misra PR, Khar RK. Vesicular systems: An overview. Indian J Pharm Sci. 2006; 68: 141- 153.

Faiyaz S, Baboota S, Ahuja A, Ali J, Aquil M, Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech. 2007; 8: Article 104.

Devaraj GN, Prakash SR, Devaraj R, Apte SS, Rao BR, Rambhav D. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. Journal of Colloidal and Interface Science 2002; 251:360- 365.

Azmin MN, Florence AT, Handjani-Vila RM, Stuart JFB, Vanlerberghe G, Whittaker JS. The effects of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J Pharm Pharmacol. 1985; 37: 237-242.

Uchegbu IF, Double JA, Turton JA, Florence AT. Niosome encapsulation of a doxorubicin polymer conjugates. Pharm Res. 1995; 12: 1019-1024.

Parthasarathi G, Udupa N, Umadevi P, Pillai GK. Pharmacokinectic evaluation of surfactant vesicles containing methotrexate in tumor bearing mice. Int J Pharm. 1990; 61:75-80.

Hunter CA, Dolan TF, Coombs GH and Baillie AJ. Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis, J Pharm. Pharmacol. 1988; 3: 161-165.

Yoshida H, Lehr CM, Kok W, Junginger HE, Verhoef JC Bouwistra JA. Niosomes for oral delivery of peptide drugs. J Control Rel. 1992; 8: 145-153.

Satturwar PM, Fulzele SV, Nande VS, Khandare JN. Formulation and evaluation of ketoconazole niosomes. Indian J Pharm Sci. 2002; 4:155-158.

Jain NK, Ramteke S, Maheshwari U. Clarithromycin based oral sustained release nanoparticle drug delivery system. Indian J Pharm Sci. 2006; 4: 479.

Kondawar MS, Kamble KG, Malusar MK, Waghmare JJ, Shah ND. Proniosomes based drug delivery system for clotrimazole. Research Journal of Pharmacy and Technology 2011; 4: 1284.

Published

01-07-2014
Statistics
Abstract Display: 690
PDF Downloads: 592
Dimension Badge

How to Cite

“PRONIOSOMES: A SUPERIOR DRUG DELIVERY SYSTEM”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 6, no. 3, July 2014, pp. 178-82, https://doi.org/10.25004/IJPSDR.2014.060301.

Issue

Section

Review Article

How to Cite

“PRONIOSOMES: A SUPERIOR DRUG DELIVERY SYSTEM”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 6, no. 3, July 2014, pp. 178-82, https://doi.org/10.25004/IJPSDR.2014.060301.

Most read articles by the same author(s)